Glenmark Generics Limited (GGL), a subsidiary of Glenmark Pharmaceuticals Limited, has received ANDA approval from the United States Food and Drug Administration
(USFDA) for Alclometasone Dipropionate Cream, 0.05%. The company will commence marketing and distribution of this product in the US market immediately.

Alcometasone Dipropionate is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Glenmark's product is the AB rated generic equivalent of GSK's Aclovate cream and will be manufactured at Glenmark's U. S. FDA approved state of the art semi-solid facility located in Baddi, India.

Glenmark's current portfolio consists of over 40 products authorized for distribution in the U. S. marketplace.